(Alliance News) - Mediclinic International PLC on Friday said its revenue in the first half of its current financial year was ahead of pre-pandemic levels across all three divisions.
The Stellenbosch, South Africa-based private hospitals operator delivered 12% revenue growth to GBP1.58 billion in the six months to September 30. Its performance was driven by a recovery in patient activity across all three divisions.
When compared with pre-pandemic, revenue was up 4% at the group, with Hirslanden and Mediclinic Middle East delivering volumes in excess of pre-pandemic levels.
Mediclinic also reported an earnings before interest, tax, depreciation and amortization margin of around 15.5%, up from 12.1% a year ago, benefiting from margin improvements at all three divisions. The company said it has established various initiatives to support the return towards pre-Covid-19 profitability at all divisions.
"The strong first-half delivered by Mediclinic Middle East, combined with a robust performance at Hirslanden in Switzerland, positions us well heading into the second-half of the year," said Chief Executive Ronnie van der Merwe.
Mediclinic shares were trading 6.2% higher in London on Friday at 328.00 pence each, while in Johannesburg, the stock was up 5.1% at ZAR65.88 a share.
The company will report its half-year results on November 11, it said.
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
